Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)

NCT04823585 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT04823585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04823585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)
Lead sponsor
Helsinki University Central Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 12, 2021
Completion date
January 16, 2025
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, aspirin-induced, chronic rhinosinusitis with nasal polyps